We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$508M
1-Year Est. Return
14.21%
This Fund
S&P 500
This Quarter
Est. Return
+6.17%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$352M
AUM Growth
+$4.47M
(+1.3%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-3.71%
Top 10 Holdings %
Top 10 Hldgs %
48.37%
Holding
101
New
3
Increased
36
Reduced
26
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$14.1M |
| 2 |
PayPal
PYPL
|
+$3.85M |
| 3 |
UnitedHealth
UNH
|
+$3.8M |
| 4 |
United Rentals
URI
|
+$1.86M |
| 5 |
MetLife
MET
|
+$268K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$13.6M |
| 2 |
Kinder Morgan
KMI
|
+$12.1M |
| 3 |
Medtronic
MDT
|
+$9.79M |
| 4 |
Omnicom Group
OMC
|
+$1.06M |
| 5 |
Altria Group
MO
|
+$446K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.63% |
| 2 | Healthcare | 17.39% |
| 3 | Industrials | 11.64% |
| 4 | Financials | 11.16% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.81T
| $24.6M | 7% |
72,289
+48
| +0.1% | +$15K |
|
2
Quanta Services
PWR
$90.6B
| $20M | 5.69% |
101,870
-385
| -0.4% | -$67.2K |
|
3
Lowe's Companies
LOW
$117B
| $18.5M | 5.26% |
81,931
+64
| +0.1% | +$13.3K |
|
|
4
Omnicom Group
OMC
$24.2B
| $17.1M | 4.86% |
179,791
-11,436
| -6% | -$1.06M |
|
5
Labcorp
LH
$27.2B
| $16.9M | 4.81% |
81,676
+537
| +0.7% | +$104K |
|
|
PRFT
6
DELISTED
Perficient Inc
PRFT
| $16.1M | 4.58% |
193,345
+1,275
| +0.7% | +$93.9K |
|
|
7
United Rentals
URI
$64.1B
| $15.1M | 4.29% |
33,861
+5,012
| +17% | +$1.86M |
|
8
Check Point Software Technologies
CHKP
$14.1B
| $14.6M | 4.15% |
116,359
+395
| +0.3% | +$49.7K |
|
9
Keysight
KEYS
$54.5B
| $13.9M | 3.94% |
82,840
+675
| +0.8% | +$105K |
|
|
FISV
10
Fiserv Inc
FISV
$28.3B
| $13.3M | 3.79% |
105,808
+175
| +0.2% | +$20.6K |
|
|
11
Nasdaq
NDAQ
$55.5B
| $12.9M | 3.68% |
+259,577
| New | +$14.1M |
|
12
Vertex Pharmaceuticals
VRTX
$137B
| $12.5M | 3.56% |
35,580
+231
| +0.7% | +$77.8K |
|
13
Williams-Sonoma
WSM
$27.7B
| $12.4M | 3.51% |
197,570
+1,750
| +0.9% | +$104K |
|
14
Broadridge
BR
$20.9B
| $10.5M | 2.99% |
63,554
+275
| +0.4% | +$41.6K |
|
|
15
PayPal
PYPL
$45.9B
| $10.1M | 2.87% |
151,558
+56,471
| +59% | +$3.85M |
|
16
Becton Dickinson
BDX
$51.6B
| $9.99M | 2.84% |
37,837
+221
| +0.6% | +$56.1K |
|
17
Zebra Technologies
ZBRA
$16.9B
| $8.63M | 2.45% |
29,156
+375
| +1% | +$105K |
|
18
Accenture
ACN
$116B
| $8.14M | 2.31% |
26,382
+260
| +1% | +$75.6K |
|
19
Truist Financial
TFC
$61.6B
| $6.95M | 1.98% |
229,139
-2,371
| -1% | -$73.6K |
|
20
JPMorgan Chase
JPM
$951B
| $6.58M | 1.87% |
45,210
-227
| -0.5% | -$31.2K |
|
21
Workday
WDAY
$49.3B
| $6.38M | 1.81% |
28,227
+285
| +1% | +$57.1K |
|
22
Thermo Fisher Scientific
TMO
$230B
| $6.26M | 1.78% |
11,994
+210
| +2% | +$113K |
|
23
Apple
AAPL
$4.67T
| $5.82M | 1.65% |
29,997
-376
| -1% | -$65.5K |
|
24
Salesforce
CRM
$211B
| $5.77M | 1.64% |
27,317
+495
| +2% | +$101K |
|
25
Skyworks Solutions
SWKS
$9.9B
| $4.77M | 1.36% |
43,125
+705
| +2% | +$74.4K |
|
Similar funds
5NPW
BFA
HC
RIG
FSA
IIC
REMPR
OPA
McRae Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, McRae Capital Management held 101 positions worth $352M, up 1.3% from $347M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
McRae Capital Management withdrew a net $13M in Q2 2023, closing 5 positions and reducing 26 holdings. Its most notable exit was Medtronic, an estimated $9.79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, McRae Capital Management opened a new position in Nasdaq worth $12.9M.
- McRae Capital Management's largest Q2 2023 buy was Nasdaq: 259,577 shares worth $12.9M.
- McRae Capital Management added most to PayPal in Q2 2023, an estimated $3.85M increase.
- McRae Capital Management's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $13.6M.
- McRae Capital Management fully exited Medtronic in Q2 2023, selling an estimated $9.79M.
- McRae Capital Management's ten largest holdings make up 48% of its $352M portfolio in Q2 2023.
- McRae Capital Management opened 3 new positions and closed 5 in Q2 2023.
- McRae Capital Management's portfolio value rose 1.3% quarter-over-quarter to $352M.
Based on McRae Capital Management's 13F filing for Q2 2023, filed 21 Jul 2023.